Drug Price Trends for HM MOTION RELIEF

Average Pharmacy Cost for HM MOTION RELIEF

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
HM MOTION RELIEF 25 MG TABLET	62011-0345-01	0.11933	EACH	2024-12-18
HM MOTION RELIEF 25 MG TABLET	62011-0345-01	0.12136	EACH	2024-11-20
HM MOTION RELIEF 25 MG TABLET	62011-0345-01	0.11948	EACH	2024-10-23
HM MOTION RELIEF 25 MG TABLET	62011-0345-01	0.12147	EACH	2024-09-18

Market Analysis and Price Projections for Motion Sickness Treatment: A Comprehensive Overview

Market Size and Growth Projections

The global motion sickness treatment market is experiencing steady growth, driven by several key factors. As of 2021, the market size was valued at $393.7 million and is projected to reach $525 million by 2031, growing at a Compound Annual Growth Rate (CAGR) of 2.9%[1].

Drivers of Market Growth

Increasing Incidence of Motion Sickness

Motion sickness affects a significant portion of the population, with around 10% being more prone to it than others. This increasing incidence is a major driver of the market growth, as more people seek effective treatments[1].

Product Approvals and Innovations

The recent rise in product approvals for motion sickness medications, including generic and branded versions of transdermal patches, has boosted the adoption of these treatments. This trend is expected to continue, fueling market growth[1].

Consumer Awareness and Accessibility

Increased consumer awareness about preventive healthcare and the ease of accessibility of medications have also contributed to the market's expansion. Promotional activities by manufacturers further enhance the adoption of new products[1].

Market Segmentation

By Drug Class

The motion sickness treatment market is segmented into several drug classes, with antihistamines holding the largest market share in 2021. Antihistamines are preferred due to their low cost, over-the-counter availability, and effectiveness in reducing motion sickness. Key players such as Sun Pharmaceutical Industries Ltd., WellSpring Pharmaceutical Corporation, and Prestige Consumer Healthcare Inc. are major contributors to this segment[1].

Anticholinergics, particularly scopolamine transdermal patches, are anticipated to grow at the fastest rate during the forecast period due to their effectiveness in preventing motion sickness[1].

By Route of Administration

The market is bifurcated into oral and other routes of administration. Oral medications are widely used, but transdermal patches are gaining popularity due to their convenience and efficacy[3].

By Distribution Channel

The market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. Online pharmacies are becoming increasingly popular due to their convenience and accessibility[3].

By Region

North America dominated the global market in 2021 and is expected to maintain its dominance. The U.S. is the prime market in North America, with Mexico expected to grow at the fastest rate. The well-developed healthcare infrastructure and government support in North America are key contributing factors to this dominance[1].

Key Market Players

The global motion sickness treatment market includes several key players such as Prestige Consumer Healthcare Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Limited, Novartis AG, WellSpring Pharmaceutical Corporation, Viatris Inc., Zydus Lifesciences Limited, Baxter International Inc., and Abbott Laboratories. These companies are driving innovation and market growth through new product introductions and promotional activities[1].

Market Trends and Forecasts

Increasing Adoption of OTC Medications

There is a growing preference for over-the-counter (OTC) solutions, which is strengthening the business case for motion sickness treatments. This trend is expected to continue, driving market growth[3].

Technological Advancements

Technological advancements in the production and development of formulations have increased production capacity, efficacy, and quality of medications. This has significantly contributed to the market's revenue generation and is expected to continue doing so[1].

Geographic Expansion

The market is analyzed across various geographic regions, including North America, Europe, Asia-Pacific, and Latin America, Middle East, and Africa (LAMEA). Each region presents unique opportunities and challenges, with North America and Europe being the most lucrative markets due to their well-developed healthcare infrastructures[1][4].

Price Projections

The global motion sickness treatment market is projected to grow from $755.4 million in 2023 to $863.2 million by 2030, at a CAGR of 1.9%[3].

Antihistamines and Anticholinergics

Antihistamines, being the largest segment, are expected to maintain their dominance due to their cost-effectiveness and widespread availability. Anticholinergics, particularly scopolamine transdermal patches, are anticipated to grow rapidly due to their high efficacy[1].

Regional Price Variations

Prices for motion sickness treatments vary by region, with North America and Europe generally having higher prices due to the adoption of expensive prescription drugs. In contrast, developing economies are expected to see increased adoption of affordable OTC medications, contributing to market growth[4].

Analyst Insights

According to top-level CXOs in the global motion sickness treatment market, the increasing demand for efficient and high-quality medications, along with the rise in adoption of OTC medications, will offer profitable opportunities for market expansion. Technological advancements and increased awareness about motion sickness treatments are also significant drivers of market growth[1].

Key Takeaways

• The global motion sickness treatment market is projected to reach $525 million by 2031, growing at a CAGR of 2.9%.
• Antihistamines hold the largest market share, while anticholinergics are expected to grow at the fastest rate.
• North America dominates the market, driven by a well-developed healthcare infrastructure and government support.
• Increasing consumer awareness and the ease of accessibility of medications are key drivers of market growth.
• Technological advancements in medication production are enhancing market revenue.

FAQs

What is the current market size of the global motion sickness treatment market?

The global motion sickness treatment market was valued at $393.7 million in 2021[1].

What is the projected growth rate of the motion sickness treatment market?

The market is projected to grow at a CAGR of 2.9% from 2021 to 2031[1].

Which drug class holds the largest market share in the motion sickness treatment market?

Antihistamines hold the largest market share due to their low cost, over-the-counter availability, and effectiveness[1].

What are the key drivers of the motion sickness treatment market?

Key drivers include the increasing incidence of motion sickness, product approvals, consumer awareness, and technological advancements in medication production[1].

Which region dominates the global motion sickness treatment market?

North America dominates the global market, with the U.S. being the prime market in this region[1].

What is the role of anticholinergics in the motion sickness treatment market?

Anticholinergics, particularly scopolamine transdermal patches, are expected to grow at the fastest rate due to their high efficacy in preventing motion sickness[1].

Sources

1. Allied Market Research: Motion Sickness Treatment Market Statistics | Projection - 2031
2. GlobeNewswire: The Global Market for Motion Sickness Treatment, 2024-2030
3. Transparency Market Research: Motion Sickness Treatment Market Analysis Report 2026
4. Transparency Market Research: Motion Sickness Treatment Market Analysis and Forecast